Genetic and epigenetic heterogeneity in acute myeloid leukemia
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Genetic and epigenetic heterogeneity is emerging as a fundamental property of human cancers. Reflecting the genesis of tumors as an evolutionary process driven by clonal selection. The complexity of clonal architecture has been known for many years in the setting of acute myeloid leukemia (AML), based on karyotyping studies. However the true complexity of AMLs is only now being understood thanks to in depth genome sequencing studies in humans, which reveal that heterogeneity is a multilayered and involves not only the genome but also the epigenome. Here, we review recent advances in genetic and epigenetic heterogeneity and clonal dynamics in AML and their relevance to biology, clinical outcomes and therapeutic implications. Special attention is focused on somatic mutations affecting regulators of cytosine methylation, since these tend to occur early in disease evolution, reprogram the epigenome of hematopoietic stem cells, and are linked to unfavorable outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Self-citationClonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., et al. (2013) · Science · doi:10.1126/science.1234769 · Cited by 804
Corces-Zimmerman, M. R., Hong, W.-J., Weissman, I. L., Medeiros, B. C., & Majeti, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324297111 · Cited by 705
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513
Self-citationRussler-Germain, D. A., Spencer, D. H., Young, M. A., Lamprecht, T. L., Miller, C. A., Fulton, R., Meyer, M. R., Erdmann-Gilmore, P., Townsend, R. R., Wilson, R. K., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.010 · Cited by 452
Large conserved domains of low DNA methylation maintained by Dnmt3a
Jeong, M., Sun, D., Luo, M., Huang, Y., Challen, G. A., Rodriguez, B., Zhang, X., Chavez, L., Wang, H., Hannah, R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2836 · Cited by 324
Shih, A. H., Jiang, Y., Meydan, C., Shank, K., Pandey, S., Barreyro, L., Antony-Debre, I., Viale, A., Socci, N., Sun, Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.009 · Cited by 236
Self-citationNew IDH1 mutant inhibitors for treatment of acute myeloid leukemia
Okoye-Okafor, U. C., Bartholdy, B., Cartier, J., Gao, E. N., Pietrak, B., Rendina, A. R., Rominger, C., Quinn, C., Smallwood, A., Wiggall, K. J., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1930 · Cited by 180
Celik, H., Mallaney, C., Kothari, A., Ostrander, E. L., Eultgen, E., Martens, A., Miller, C. A., Hundal, J., Klco, J. M., & Challen, G. A. (2015) · Blood · doi:10.1182/blood-2014-08-594564 · Cited by 95
Research works printed but not linked: 25
- Gilliland, 2002, The roles of FLT3 in hematopoiesis and leukemia, Blood, 100, 1532, 10.1182/blood-2002-02-0492 · DOI · Paper page
- Paguirigan, 2015, Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia, Sci Transl Med, 7, 281re282, 10.1126/scitranslmed.aaa0763 · DOI · Paper page
- Li, 2014, Dynamic evolution of clonal epialleles revealed by methclone, Genome Biol, 15, 472, 10.1186/s13059-014-0472-5 · doi:10.1186/s13059-014-0472-5
- Klco, 2014, Functional heterogeneity of genetically defined subclones in acute myeloid leukemia, Cancer Cell, 25, 379, 10.1016/j.ccr.2014.01.031 · DOI · Paper page
- Kronke, 2013, Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia, Blood, 122, 100, 10.1182/blood-2013-01-479188 · DOI · Paper page
- Figueroa, 2010, DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, 17, 13, 10.1016/j.ccr.2009.11.020 · DOI · Paper page
- Scourzic, 2015, TET proteins and the control of cytosine demethylation in cancer, Genome Med, 7, 9, 10.1186/s13073-015-0134-6 · DOI · Paper page
- McKenney, 2013, Isocitrate dehydrogenase mutations in leukemia, J Clin Invest, 123, 3672, 10.1172/JCI67266 · DOI
- Rampal, 2014, DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia, Cell Rep, 9, 1841, 10.1016/j.celrep.2014.11.004 · DOI · Paper page
- Wang, 2015, WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation, Mol Cell, 57, 662, 10.1016/j.molcel.2014.12.023 · DOI · Paper page
- Patel, 2012, Prognostic relevance of integrated genetic profiling in acute myeloid leukemia, N Engl J Med, 366, 1079, 10.1056/NEJMoa1112304 · DOI · Paper page
- Ribeiro, 2012, Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia, Blood, 119, 5824, 10.1182/blood-2011-07-367961 · DOI · Paper page
- Holz-Schietinger, 2012, Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation, J Biol Chem, 287, 30941, 10.1074/jbc.M112.366625 · DOI · Paper page
- Challen, 2012, Dnmt3a is essential for hematopoietic stem cell differentiation, Nat Genet, 44, 23, 10.1038/ng.1009 · DOI · Paper page
- Ferreira, 2015, DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia, Oncogene
- Mayle, 2015, Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation, Blood, 125, 629, 10.1182/blood-2014-08-594648 · DOI · Paper page
- Guryanova, 2015, Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells, Leukemia
- Shaknovich, 2014, Epigenetic diversity in hematopoietic neoplasms, Biochim Biophys Acta, 1846, 477
- Hansen, 2011, Increased methylation variation in epigenetic domains across cancer types, Nat Genet, 43, 768, 10.1038/ng.865 · DOI · Paper page
- Brocks, 2014, Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer, Cell Rep, 8, 798, 10.1016/j.celrep.2014.06.053 · DOI · Paper page
- Landau, 2014, Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia, Cancer Cell, 26, 813, 10.1016/j.ccell.2014.10.012 · DOI · Paper page
- Pan, 2015, Epigenomic evolution in diffuse large B-cell lymphomas, Nat Commun, 6, 6921, 10.1038/ncomms7921 · DOI · Paper page
- De, 2013, Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity, PLoS Genet, 9, e1003137, 10.1371/journal.pgen.1003137 · DOI · Paper page
- Alizadeh, 2015, Toward understanding and exploiting tumor heterogeneity, Nat Med, 21, 846, 10.1038/nm.3915 · DOI · Paper page
- Kernytsky, 2015, IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition, Blood, 125, 296, 10.1182/blood-2013-10-533604 · DOI · Paper page
Cited by
Jacobs, M., He, J., F. Pradier, M., Lam, B., Ahn, A. C., McCoy, T. H., Perlis, R. H., Doshi-Velez, F., & Gajos, K. Z. (2021) · Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3411764.3445385 · Cited by 177
Ferrando, A. A., & López-Otín, C. (2017) · Nature Medicine · doi:10.1038/nm.4410 · Cited by 120
Pavlovic, N. V., GILOTRA, N. A., LEE, C. S., NDUMELE, C., MAMMOS, D., DENNISONHIMMELFARB, C., & AbshireSaylor, M. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.005 · Cited by 58
Metadata
- Authors
- Li, S., Mason, C. E., & Melnick, A.
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 36
- Pages
- 100-106
- ISSN
- 0959-437X (ISSN-L)
- OpenAlex
- W2362534374
- Cited by
- 193
- References
- 15
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.